CENTOGENE Announces Temporary Leave of Absence of Holger Friedrich from the Supervisory Board
CENTOGENE Announces Temporary Leave of Absence of Holger Friedrich from the Supervisory Board
November 21, 2019
CAMBRIDGE, Mass. and ROSTOCK and BERLIN, Germany, November 21, 2019 (GLOBE NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, announced today that Holger Friedrich, a member of the Company’s supervisory board, will with immediate effect take a temporary leave of absence from the Supervisory Board.